Table 6.
Solicited adverse reaction | No. (%) experiencing an adverse event |
|||
---|---|---|---|---|
Healthy children (N = 68) |
Children with recurrent wheezing (N = 62) |
|||
Any event | Grade ≥2 event | Any event | Grade ≥2 event | |
Local | ||||
Tenderness | 16 (23.53) | 0 | 10 (16.13) | 0 |
Pain | 15 (22.06) | 0 | 10 (16.13) | 1 |
Redness | 4 (5.88) | 0 | 3 (4.84) | 1 |
Swelling | 2 (2.94) | 0 | 1 (1.61) | 0 |
Subtotal | 20 (29.41) | 0 | 13 (20.97) | 2 |
Systemic | ||||
Fever | 9 (13.24) | 9 (13.24) | 8 (12.90) | 8 (12.90) |
Fatigue | 11 (16.18) | 1 (1.47) | 5 (8.06) | 0 (0.00) |
Drowsiness | 10 (14.71)a | 1 (1.47) | 2 (3.23) | 0 (0.00) |
Sweating | 5 (7.35) | 2 (2.94) | 2 (3.23) | 1 (1.61) |
Headache | 3 (4.41) | 0 (0.00) | 3 (4.84) | 0 (0.00) |
Myalgia | 4 (5.88) | 0 (0.00) | 1 (1.61) | 0 (0.00) |
Shivering | 1 (1.47) | 1 (1.47) | 2 (3.23) | 1 (1.61) |
Arthralgia | 1 (1.47) | 0 (0.00) | 0 (0.00) | 0 (0.00) |
Subtotal | 18 (26.47) | 9 (13.24) | 13 (20.97) | 8 (12.90) |
P = 0.0239 (calculated with the chi-square test).